Inhibitors of Serine Proteases, Particularly HCV NS3-NS4A Protease

Details for Australian Patent Application No. 2012202822 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Cottrell, Kevin M.; Deininger, David D.; Farmer, Luc J.; Pitlik, Janos; Perni, Robert B.; Court, John J.

Agent Cullens

Pub. Number AU-A-2012202822

Parent 2005212257

Filing date 15 May 2012

Wipo publication date 7 June 2012

International Classifications

C07K 5/02 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 7/02 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 14/18 (2006.01) Peptides having more than 20 amino acids

Event Publications

31 May 2012 Complete Application Filed

7 June 2012 Application Open to Public Inspection

  Published as AU-A-2012202822

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012202823-Methods and Products for Evaluating an Immune Response to a Therapeutic Protein

2012202821-Program Guide System With Videoon-Demand Browsing